ZENTALIS PHARMACEUTICALS INC's ticker is ZNTL and the CUSIP is 98943L107. A total of 105 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $244,392 | -15.4% | 12,183 | +19.0% | 0.00% | 0.0% |
Q2 2023 | $288,786 | +33.3% | 10,237 | -4.9% | 0.00% | 0.0% |
Q4 2022 | $216,686 | -0.1% | 10,759 | +7.9% | 0.00% | 0.0% |
Q3 2022 | $217,000 | -11.4% | 9,968 | +14.1% | 0.00% | 0.0% |
Q2 2022 | $245,000 | -54.1% | 8,738 | -24.4% | 0.00% | 0.0% |
Q1 2022 | $534,000 | -55.7% | 11,556 | -19.5% | 0.00% | -50.0% |
Q4 2021 | $1,206,000 | +27.3% | 14,350 | +0.9% | 0.00% | -33.3% |
Q3 2021 | $947,000 | +10.9% | 14,218 | -11.4% | 0.00% | +50.0% |
Q2 2021 | $854,000 | +48.0% | 16,048 | +20.6% | 0.00% | 0.0% |
Q1 2021 | $577,000 | -12.0% | 13,303 | +5.3% | 0.00% | 0.0% |
Q4 2020 | $656,000 | – | 12,638 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 2,664,409 | $177,556,000 | 4.47% |
Avidity Partners Management LP | 2,493,800 | $166,187,000 | 3.68% |
Matrix Capital Management Company, LP | 4,349,279 | $289,836,000 | 3.30% |
Integral Health Asset Management, LLC | 90,000 | $5,998,000 | 1.72% |
Affinity Asset Advisors, LLC | 77,500 | $5,165,000 | 1.30% |
Ghost Tree Capital, LLC | 65,000 | $4,332,000 | 1.27% |
Ikarian Capital, LLC | 200,000 | $13,328,000 | 0.94% |
HighVista Strategies LLC | 20,596 | $1,373,000 | 0.91% |
SILVERARC CAPITAL MANAGEMENT, LLC | 23,855 | $1,590,000 | 0.90% |
Woodline Partners LP | 507,847 | $33,843,000 | 0.55% |